臨床検査の世界市場：市場規模・シェア・動向分析 (種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

臨床検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床検査の市場規模は2030年までに2,130億4,000万米ドルに達し、2025年から2030年までのCAGRは8.88％を記録すると推定されています。

臨床検査市場の成長は、対象疾患の有病率の上昇に起因しています。臨床検査の使用は、適切な診断と治療の評価と策定につながる患者の健康に主に焦点を当てた多種多様な診断目的での検査の使用により増加傾向にあります。

世界の高齢者人口は増加しており、心血管疾患や腎機能障害などの疾患開発の最大の危険因子と考えられています。WHOによると、60歳以上の人口は2030年には6人に1人になると予想されており、2020年の10億人から2030年には14億人に増加します。さらに、2050年には80歳以上の人口は15億人以上と倍増し、80歳以上の人口は3倍の4,260億人に達すると予測されています。このように、老人人口の増加は、予測期間中、同市場にとってインパクトの大きい市場促進要因になると予想されます。

CVDや糖尿病などの対象疾患の有病率の増加は、予測期間を通じて市場を押し上げると予想されます。CVDは致死的であり、世界の死因のトップです。心血管疾患に関するアンメット・メディカル・ニーズの高さと、それに伴う患者の意識の高まりは、ポイントオブケア脂質検査の需要を押し上げると予想される要因の一つです。WHOによると、2021年、心血管疾患は過去30年間における世界の死亡率および罹患率の主要原因であり、177億人が心血管疾患により毎年死亡しており、これは世界の全死亡者の31％にあたる。

さらに、臨床検査の開発・製剤化に携わる主な企業は、新規の結核治療薬を開発し、市場開拓における競争力を維持するために、共同研究やパートナーシップに注力しています。さらに、ラボラトリーオートメーションシステムの採用が増加していることも、予測期間中に市場を押し上げると予想されます。例えば、2023年1月[、BD社は、微生物検査室の検体処理を自動化する第3世代のトータルラボラトリーオートメーションシステムを発売しました。さらに、2023年1月には、NovoPath LLC社が腫瘍検査室向けのLISソリューションを拡充しました。

臨床検査市場レポートハイライト

• 種類別では、HbA1c検査分野が2024年に12.39%の最大市場シェアを占め、主に糖尿病とコレステロール関連疾患の世界の有病率の上昇が牽引しました。
• HGB/HCT検査分野は、予測期間中に最も速いCAGRで成長すると予測されています。
• 最終用途別では、中央検査室セグメントが2024年に市場で最大のシェアを占めました。
• プライマリ・クリニックの最終用途分野は、予測期間中に最も速いCAGRを記録する見込みです。
• 北米の臨床検査産業は2024年に市場で最大のシェアを占め、今後も支配的な地位を維持すると予測されます。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 臨床検査市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場動向と展望
• 市場力学
  • 慢性疾患の有病率の上昇
  • 技術の進歩
  • 高齢化人口の増加
• 市場抑制要因分析
  • 規制上の課題と曖昧さ
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
• 市場機会分析
• 市場の新興戦略

第4章 臨床検査市場：種類別の推定・動向分析

• 臨床検査市場：種類別の変動分析
• 種類別
• 全血球数
• HGB/HCT検査
• ファンデーション代謝パネル
• BUNクレアチニン検査
• 電解質検査
• HbA1c検査
• 包括的な代謝パネル検査
• 肝臓パネル検査
  • 肝炎
  • 胆管閉塞
  • 肝硬変
  • 肝臓がん
  • 骨疾患
  • 自己免疫疾患
  • その他
• 腎臓パネル検査
• その他
• 微生物学市場、2018年～2030年
• 病原体検査

第5章 臨床検査市場：最終用途別の推定・動向分析

• 臨床検査市場：最終用途別の変動分析
• 最終用途別
• プライマリクリニック
  • 全血球数
  • HGB/HCT検査
  • ファンデーション代謝パネル
  • BUNクレアチニン検査
  • 電解質検査
  • HbA1c検査
  • 包括的な代謝パネル検査
  • 肝臓パネル検査
  • 腎臓パネル検査
  • 脂質パネル検査
  • その他
• 中央検査室
  • 全血球数
  • HGB/HCT検査
  • ファンデーション代謝パネル
  • BUNクレアチニン検査
  • 電解質検査
  • HbA1c検査
  • 包括的な代謝パネル検査
  • 肝臓パネル検査
  • 腎臓パネル検査
  • 脂質パネル検査
  • その他

第6章 臨床検査市場：地域別の推定・動向分析

• 臨床検査の市場シェア：地域別（2024年・2030年）
• 市場シェア分析：地域別（2024年・2030年）
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 市場規模の予測と動向分析（2018～2030年）
• 北米
  • 北米の臨床検査市場（2018～2030年）
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の臨床検査市場（2018～2030年）
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の臨床検査市場（2018～2030年）
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの臨床検査市場（2018～2030年）
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの臨床検査市場（2018～2030年）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 最近の動向と影響分析：主要市場参入企業別
• 企業分類
• 戦略マッピング
• 企業市場シェア分析（2024年）
• 企業プロファイル
  • Quest Diagnostics Incorporated.
  • Abbott
  • Cinven
  • Laboratory Corporation of America Holdings
  • ARUP Laboratories
  • OPKO Health, Inc.
  • UNILABS
  • Clinical Reference Laboratory, Inc.
  • Synnovis Group LLP
  • Sonic Healthcare Limited.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 Incidence of Diseases
• Table 4 Global Clinical Laboratory Tests Market, By Region, 2018 - 2030 (USD Billion)
• Table 5 North America Clinical Laboratory Tests Market, By Country, 2018 - 2030 (USD Billion)
• Table 6 North America Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 7 North America Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 8 U.S. Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 9 U.S. Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 10 Canada Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 11 Canada Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 12 Mexico Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 13 Mexico Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 14 Europe Clinical Laboratory Tests Market, By Country, 2018 - 2030 (USD Billion)
• Table 15 Europe Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 16 Europe Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 17 Germany Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 18 Germany Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 19 UK Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 20 UK Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 21 France Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 22 France Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 23 Italy Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 24 Italy Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 25 Spain Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 26 Spain Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 27 Denmark Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 28 Denmark Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 29 Sweden Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 30 Sweden Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 31 Norway Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 32 Norway Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 33 Asia Pacific Clinical Laboratory Tests Market, By Country, 2018 - 2030 (USD Billion)
• Table 34 Asia Pacific Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 35 Asia Pacific Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 36 Japan Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 37 Japan Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 38 China Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 39 China Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 40 India Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 41 India Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 42 Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 43 South Korea Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 44 Australia Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 45 Australia Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 46 Thailand Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 47 Thailand Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 48 Latin America Clinical Laboratory Tests Market, By Country, 2018 - 2030 (USD Billion)
• Table 49 Latin America Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 50 Latin America Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 51 Brazil Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 52 Brazil Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 53 Argentina Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 54 Argentina Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 55 Middle East & Africa Clinical Laboratory Tests Market, By Country, 2018 - 2030 (USD Billion)
• Table 56 Middle East & Africa Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 57 Middle East & Africa Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 58 Saudi Arabia Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 59 Saudi Arabia Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 60 South Africa Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 61 South Africa Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 62 UAE Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 63 UAE Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)
• Table 64 Kuwait Clinical Laboratory Tests Market, By Type, 2018 - 2030 (USD Billion)
• Table 65 Kuwait Clinical Laboratory Tests Market, By End Use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Clinical Laboratory Tests Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 Penetration & Growth Prospect Mapping
• Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 13 Porter's Five Forces Analysis
• Fig. 14 Market Penetration & Growth Prospect Mapping
• Fig. 15 Clinical laboratory tests market: Type outlook and key takeaways
• Fig. 16 Clinical laboratory tests market: Type movement analysis & market share 2024 & 2030
• Fig. 17 CBC clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 18 HGB/HCT test clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 19 Basic metabolic panel clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 20 BUN creatinine test clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 21 Electrolyte tests clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 22 HbA1c tests clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 23 Comprehensive metabolic panel clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 24 Liver panel test clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 25 Hepatitis liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 26 Bile duct obstruction liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 27 Liver cirrhosis liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 28 Liver cancer liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 29 Bone disease liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 30 Autoimmune disorders liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 31 Others liver panel tests market, 2018 - 2030 (USD Billion)
• Fig. 32 Renal panel test clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 33 Lipid panel tests clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 34 Cardiovascular panel test clinical laboratory tests market, 2018 - 2030 (USD Billion)
• Fig. 35 Clinical laboratory tests market: End Use movement analysis
• Fig. 36 Clinical laboratory tests market: End Use outlook and key takeaways
• Fig. 37 Clinical laboratory tests market: End Use movement analysis & market share 2024 & 2030
• Fig. 38 Central Laboratories market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 39 Primary Clinics market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 40 Regional Marketplace: Key Takeaways
• Fig. 41 Regional Outlook, 2024 & 2030
• Fig. 42 Regional Market Dashboard
• Fig. 43 Regional Market Place: Key Takeaways
• Fig. 44 North America, SWOT Analysis
• Fig. 45 Europe, SWOT Analysis
• Fig. 46 Asia Pacific, SWOT Analysis
• Fig. 47 Latin America, SWOT Analysis
• Fig. 48 MEA, SWOT Analysis
• Fig. 49 North America
• Fig. 50 North America Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 51 U.S.
• Fig. 52 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 53 Canada
• Fig. 54 Canada Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 55 Europe
• Fig. 56 Europe Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 57 UK
• Fig. 58 UK Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 59 Germany
• Fig. 60 Germany Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 61 France
• Fig. 62 France Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 63 Italy
• Fig. 64 Italy Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 65 Spain
• Fig. 66 Spain Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 67 Denmark
• Fig. 68 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 69 Sweden
• Fig. 70 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 71 Norway
• Fig. 72 Norway Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 73 Asia Pacific
• Fig. 74 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 75 Japan
• Fig. 76 Japan Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 77 China
• Fig. 78 China Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 79 India
• Fig. 80 India Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 81 Australia
• Fig. 82 Australia Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 83 Thailand
• Fig. 84 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 85 South Korea
• Fig. 86 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 87 Latin America
• Fig. 88 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 89 Brazil
• Fig. 90 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 91 Mexico
• Fig. 92 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 93 Argentina
• Fig. 94 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 95 MEA
• Fig. 96 MEA Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 97 South Africa
• Fig. 98 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 99 Saudi Arabia
• Fig. 100 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 101 UAE
• Fig. 102 UAE Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 103 Kuwait
• Fig. 104 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Billion)
• Fig. 105 Strategy Mapping

Clinical Laboratory Tests Market Growth & Trends:

The global clinical laboratory tests market size is estimated to reach USD 213.04 billion by 2030, registering a CAGR of 8.88% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights:

• Based on type, the HbA1c testing segment held the largest market share at 12.39% in 2024, driven primarily by the rising global prevalence of diabetes and cholesterol-related conditions.
• The HGB/HCT testing type segment is projected to grow at the fastest CAGR during the forecast period.
• By end-use, the central laboratories segment held the largest share of the market in 2024, primarily due to high test volumes and widespread market penetration.
• The primary clinics end-use segment is expected to register the fastest CAGR during the forecast period.
• North America clinical laboratory tests industry held the largest share of market in 2024 and is expected to maintain its dominant position.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Tests Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
  • 3.4.1. Rising Prevalence of Chronic Diseases
  • 3.4.2. Technological Advancements
  • 3.4.3. Growing Geriatric Population
• 3.5. Market Restraint Analysis
  • 3.5.1. Regulatory Challenges and Ambiguity
• 3.6. Industry Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL Analysis
• 3.7. Market Opportunity Analysis
• 3.8. Market Emerging Statergies

Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

• 4.1. Clinical Laboratory Tests Market: Type Movement Analysis
• 4.2. Clinical Laboratory Tests Market Estimates and Forecast, by Type
• 4.3. Complete Blood Count
  • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.4. HGB/HCT tests
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Basic metabolic panel
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. BUN creatinine tests
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Electrolytes testing
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. HbA1c tests
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Comprehensive metabolic panel tests
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Liver panel tests
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.2. Hepatitis
    • 4.10.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.3. Bile duct obstruction
    • 4.10.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.4. Liver Cirrhosis
    • 4.10.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.5. Liver Cancer
    • 4.10.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.6. Bone disease
    • 4.10.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.7. Autoimmune disorders
    • 4.10.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.8. Others
    • 4.10.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Renal panel tests
  • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.12. Others
  • 4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.13. Microbiology Market, 2018 - 2030 (USD Million)
  • 4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.14. Pathogen Testing
  • 4.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Laboratory Tests Market: End Use Estimates & Trend Analysis

• 5.1. Clinical Laboratory Tests Market: End Use Movement Analysis
• 5.2. Clinical Laboratory Tests Market Estimates and Forecast, by End Use
• 5.3. Primary Clinics
  • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Complete blood count
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. HGB/HCT tests
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Basic metabolic panel
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.5. BUN creatinine tests
    • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.6. Electrolytes testing
    • 5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.7. HbA1c tests
    • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.8. Comprehensive metabolic panel tests
    • 5.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.9. Liver panel tests
    • 5.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.10. Renal panel tests
    • 5.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.11. Lipid panel tests
    • 5.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.12. Others
    • 5.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Central Laboratories
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Complete blood count
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. HGB/HCT tests
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Basic metabolic panel
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. BUN creatinine tests
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Electrolytes testing
    • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. HbA1c tests
    • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Comprehensive metabolic panel tests
    • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.9. Liver panel tests
    • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.10. Renal panel tests
    • 5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.11. Lipid panel tests
    • 5.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.12. Others
    • 5.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis

• 6.1. Clinical Laboratory Tests Market Share By Region, 2024 & 2030
• 6.2. Regional Market Share Analysis, 2024 & 2030
• 6.3. Regional Market Dashboard
• 6.4. Global Regional Market Snapshot
• 6.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.6. North America
  • 6.6.1. North America Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.6.2. U.S.
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. U.S. Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.6.3. Canada
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Canada Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.6.4. Mexico
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Mexico Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.7. Europe
  • 6.7.1. Europe Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.2. UK
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. UK Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.3. Germany
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Germany Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.4. France
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. France Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.5. Italy
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Italy Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.6. Spain
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Spain Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.7. Denmark
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Denmark Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.8. Sweden
    • 6.7.8.1. Key Country Dynamics
    • 6.7.8.2. Competitive Scenario
    • 6.7.8.3. Regulatory Framework
    • 6.7.8.4. Sweden Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.9. Norway
    • 6.7.9.1. Key Country Dynamics
    • 6.7.9.2. Competitive Scenario
    • 6.7.9.3. Regulatory Framework
    • 6.7.9.4. Norway Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.8. Asia Pacific
  • 6.8.1. Asia Pacific Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.2. Japan
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Japan Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.3. China
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. China Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.4. India
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. India Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.5. Australia
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Australia Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.6. Thailand
    • 6.8.6.1. Key Country Dynamics
    • 6.8.6.2. Competitive Scenario
    • 6.8.6.3. Regulatory Framework
    • 6.8.6.4. Thailand Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.7. South Korea
    • 6.8.7.1. Key Country Dynamics
    • 6.8.7.2. Competitive Scenario
    • 6.8.7.3. Regulatory Framework
    • 6.8.7.4. South Korea Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.9. Latin America
  • 6.9.1. Latin America Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.9.2. Brazil
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Brazil Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.9.3. Argentina
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Argentina Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.10. MEA
  • 6.10.1. MEA Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.2. South Africa
    • 6.10.2.1. Key Country Dynamics
    • 6.10.2.2. Competitive Scenario
    • 6.10.2.3. Regulatory Framework
    • 6.10.2.4. South Africa Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.3. Saudi Arabia
    • 6.10.3.1. Key Country Dynamics
    • 6.10.3.2. Competitive Scenario
    • 6.10.3.3. Regulatory Framework
    • 6.10.3.4. Saudi Arabia Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.4. UAE
    • 6.10.4.1. Key Country Dynamics
    • 6.10.4.2. Competitive Scenario
    • 6.10.4.3. Regulatory Framework
    • 6.10.4.4. UAE Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.5. Kuwait
    • 6.10.5.1. Key Country Dynamics
    • 6.10.5.2. Competitive Scenario
    • 6.10.5.3. Regulatory Framework
    • 6.10.5.4. Kuwait Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Strategy Mapping
• 7.4. Company Market Share Analysis, 2024
• 7.5. Company Profiles
  • 7.5.1. Quest Diagnostics Incorporated.
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Abbott
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Cinven
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Laboratory Corporation of America Holdings
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. ARUP Laboratories
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. OPKO Health, Inc.
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. UNILABS
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Clinical Reference Laboratory, Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Synnovis Group LLP
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Sonic Healthcare Limited.
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives